Gulnara Ayupova Author
Short Communication Open Access
Author(s): Gulnara Ayupova and Regina Balametova
Pharmaceutical development includes the study of composition, technology, stability, standardization and specific activity. The purpose of our research is developing a wound-healing biological product in a gel form. The active ingredient is Bactisporin. It is a biomass of an antagonistically active strain of bacteria Bacillus subtilis 3H that has antimicotic activity against dermatophyte fungi, or Bacillus subtilis 11B isolated from natural material that suppresses a wide range of conditionally pathogenic, pathogenic bacteria and fungi. Collagen solutions with high thickening and swelling capacity in combination with acetic acid maintain normal pH at the site of inflammation, restore metabolic processes, slow down the activity ... view moreĀ»